News for BioVie Inc. (BIVI)

BioVie (BIVI) recently showcased findings from their Phase 3 NM101 study on bezisterim at the 2nd World Conference on Aging and Gerontology in Rome. The study,

BioVie (BIVI) has expanded its Board of Directors by bringing in two seasoned experts, Amy Chappell, MD, FAAN, and Kameel Farag. Chappell, who currently serves

Seasoned leaders bring deep expertise in neuroscience drug development, strategic growth, and corporate finance to support BioVie's mission CARSON CITY, Nev.,

The TSE asks firms with price to book (P/B) of less than 1 to publish turnaround plans. Around 23% of US firms have a P/B less than 1.

BioVie (BIVI) recently shared promising findings on its Alzheimer's treatment, bezisterim, during the 7th World Aging and Rejuvenation Conference in Vienna, Aus

CARSON CITY, Nev., July 09, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. ( BIVI) (”œBioVie” or the ”œCompany”), a clinical-stage company developing innovative d

BioVie Inc. (BIVI) has announced the upcoming presentation of a poster that emphasizes the patient-centered structure and accessibility of its ongoing SUNRISE-P

Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for Vivani and Cortigent stockholders

BioVie (BIVI) has initiated the Phase 2 ADDRESS-LC clinical trial aimed at testing bezisterim for alleviating neurological symptoms linked to long COVID. They h

BioVie (BIVI) has announced a virtual event taking place on Wednesday, May 28, 2025, at 12:00 PM ET. The session will feature esteemed medical professionals, in

CARSON CITY, Nev., May 14, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. ( BIVI), (”œBioVie” or the ”œCompany”), a clinical-stage company developing innovative d

BioVie (BIVI) to host a virtual KOL event discussing the Phase 2 trial of bezisterim (NE3107) for Parkinson's treatment on May 28, 2025. The SUNRISE-PD

CARSON CITY, Nev., May 07, 2025 (GLOBE NEWSWIRE) -- BioVie Inc., ( BIVI) (”œBioVie” or the ”œCompany”) a clinical-stage company developing innovative dr

**media[617409]**

BioVie (BIVI) has unveiled its new Corporate Advisory Board, featuring a distinguished group of seven leaders with extensive achievements across various fields

The seven-member Board includes Cedars-Sinai brain health leader Dr. Zaldy Tan, Parkwood marketing powerhouse Justina Omokhua, and Neuralink visionary Tim Gardn

BioVie Inc. (BIVI) has commenced patient enrollment for its Phase 2 SUNRISE-PD clinical trial. This study aims to assess the safety and efficacy of bezisterim i

SUNRISE-PD evaluating the Company's anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson's disease who have not been treated w

Sponsored by The Sustainable Green Team (OTC: SGTM), featuring Kevin Harrington - the ORIGINAL Shark from Shark Tank NEW YORK CITY, NEW YORK / ACC...